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Abstract
Respiratory distress (RD), a term utilised to summate a conglomeration of clinical features, including tachypnoea, use of accessory 
muscles of respiratory, lower chest wall indrawing, grunting, hypoxaemia and cyanosis, is useful in determining severity of illness in 
childhood. While these features commonly reflect pathology in the respiratory system, a condition accounting for the vast majority 
of the 10.8 million under-five childhood deaths occurring globally each year, dysfunction in other organ systems may also present 
with features of respiratory distress. The World Health Organization (WHO) has utilised some of these clinical findings to classify the 
severity of pneumonia and to advocate management under its programme of integrated management of childhood illness. The WHO 
has identified the following three essential steps that would help reduce mortality from pneumonia: (1) recognition of a sick child, (2) 
appropriate seeking of care, and (3) management of the underlying condition. Despite the WHO’s acknowledgement that appropriate 
implementation of these steps would have a significant impact on reaching the target of Millennium Development Goal 4 (a two-thirds 
reduction in the global under-five mortality rates between 1990 and 2015), only about one in five health caregivers knows the danger 
signs of severe respiratory distress, inappropriate behaviour in seeking care is often seen in the impoverished, poorly educated 
communities, and effective interventions are inconsistently applied.
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Introduction
Respiratory distress is the term utilised to denote a composition of 
clinical features that reflects ill health. The term was coined primarily 
to describe varying degrees of ill health in the respiratory system due 
to high morbidity and mortality from these conditions. For every four 
to nine episodes of acute respiratory infection per child occurring 
in developing countries, one-fifth results in a lower respiratory tract 
infection that causes between 11 and 20 million hospitalisations and 
2 million childhood deaths globally each year.1,2 The lastmentioned 
statistic represents 20% of the 10.8 million under-five childhood 
deaths occurring globally each year.2 These data do not take into 
consideration deaths occurring in the neonatal period, in which 26% of 
all neonatal deaths are related to severe infections.3 
Pneumonia, the commonest of these respiratory diseases, kills more 
children than the combined total of those dying from AIDS, malaria and 
measles. The clinical features utilised to describe respiratory distress 
are however of a protean nature and also reflect ill health within 
other body systems. Cardiac abnormalities such as shock; metabolic 
abnormalities such as acute diarrhoea, acute renal dysfunction, drug 
toxicity and diabetes mellitus; infectious conditions such as sepsis 
and urinary tract infections; and neurological conditions such as 
meningitis, brain stem insults-infarcts, haemorrhage and infection 
may present with clinical manifestations described as respiratory 
distress. Consequently, these features in isolation or combination are 
utilised as an entry point for the common conditions in the integrated 
management of childhood illnesses such as diarrhoea, malaria, and 
HIV disease.
Definition of respiratory distress
The principle features of the respiratory distress syndrome (RDS) are:
1.  Tachypnoea: The respiratory rate is the most reliable of the clinical 
features in denoting respiratory ill health. It is measured in a restful 
state and has a sensitivity of 62–81% and specificity of 54–70% 
for pneumonia.4–7 Rates of > 60 breaths/min, > 50 breaths/min 
and > 40 breaths/min for young infants (0–59 days), infants 
(60–365 days) and childhood (1–5 years) are regarded as being 
symptomatic of tachypnoea. The higher the respiratory rate above 
the cutoff rate, the greater the degree of respiratory distress, i.e. up 
to 10 above the cutoff threshold is regarded as mild, up to 30 above 
the cutoff threshold is regarded as moderate RDS and > 30 above 
the cutoff value is regarded as severe RDS.7–9 It must, however, be 
noted that young infants often respond to ill health with apnoea and 
hence care must be taken with evaluation of the respiratory rate at 
this age.10
2.  Use of accessory muscles for respiration: Features include use 
of sternocleidomastoid muscles, nasal alar flare and tracheal tug. 
These features are more frequently seen in children with upper 
airway disease – due to intraluminal, intramural and/or extraluminal 
upper airway obstruction, e.g. by a foreign body.
3.  Use of intercostal or subcostal muscles for respiration resulting 
in intercostal or subcostal recession – lower chest wall indrawing. 
These features suggest lower airway pathology and in the long 
term result in a Harrison’s sulcus.
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4.  Hypoxaemia: This is measured by a low oxygen saturation of 
< 90%. This feature is affected by altitude but for all areas in 
South Africa a cutoff of < 90% saturation is pathological and 
requires supplementary oxygen therapy. It should be noted that 
this feature is affected by haemoglobulin concentration, degree 
of acidosis, temperature, and 2,3 DPG, and correction of these 
factors are essential for optimising the oxygen-carrying capacity of 
blood. Saturation monitoring is an essential cost-effective part of 
monitoring any ill child and should be widely available at all levels of 
health care. Normal oxygen saturations are over 92%.
5.  Grunting: This clinical sign is generated by a patient in severe 
distress in an effort to raise the peak end expiratory pressure to 
avoid collapse of the alveoli during expiration.
6.  Cyanosis: This is a feature of severe respiratory distress and 
denotes > 5 g/dl of deoxygenated (reduced) haemoglobin. It is 
often identified centrally but occasionally peripheral cyanosis is 
recognised.
In young infants (< 2 months of age), the presence of the 
abovementioned clinical features are less reliable in predicting the 
degree of respiratory distress and therefore the presence of non-
specific signs are recommended for making such predictions. These 
signs include the inability to feed, variable temperature control (both 
hypothermia and hyperthermia), decreased level of activity and level of 
consciousness, convulsions, increased sleepiness, apnoea, increased 
chest retraction (chest wall is more compliant), hypoxaemia and 
cyanosis. In a recent multicentre study of young infants conducted 
in seven countries, history of difficult feeding, history of convulsions, 
movement only when stimulated, respiratory rate > 60 breaths/min, 
severe chest indrawing and temperature instability were most 
predictive with a sensitivity of 85% and specificity of 75% for severity 
of illness.11
Features suggestive of severe respiratory distress (danger signs 
according to IMCI) include12: 
1. Inability to feed or drink and vomiting everything
2. Convulsions
3.  Abnormal sleepiness 
4. Stridor in a calm child
5. Severe malnutrition  
Clinical signs (other than the abovementioned signs) of respiratory 
failure have been found to be most useful in detecting severe illnesses. 
Features of hypercapnia, i.e. bounding pulses and warm peripheries, 
and of hypoxaemia, i.e. initial irritability, restlessness and later 
progressing to decreased level of consciousness and convulsions, 
should be recognised immediately and elicit a rapid response 
which includes use of oxygen and possibly mechanical ventilation. 
Adventitious breath sounds such as crackles (fluid in alveoli), wheezes 
(lower airway obstruction), and bronchial breathing (parenchymal 
consolidation) are useful for determining the site and nature of the 
lesion but are poorly predictive of severity of respiratory illness and 
have a low sensitivity of 40–50%.13,14
The work of breathing as detected by chest wall compliance and elastic 
recoil is useful for detecting severity but requires greater training for 
accurate evaluation.
Risk factors for determining severity of respiratory distress
Apart from the clinical features utilised to determine respiratory 
distress, certain associated abnormalities increase the risk for 
adverse outcomes. These conditions include primary or secondary 
immune deficiencies, including HIV; severe malnutrition; structural 
abnormalities, e.g. bronchiectasis; and socio-economic characteristics, 
e.g. overcrowding, smoking and indoor pollutants (burning of wood fire 
and kerosene). Impoverished living conditions in rural environments 
place children at risk of acquiring illness and limit their access to care.
Differential diagnosis of children with respiratory distress
As mentioned above, other non-respiratory conditions must be 
considered and excluded prior to labelling a child with RDS as having a 
respiratory illness.
Cardiac illness, especially shock that is hypovolaemic, septic, 
cardiogenic, distributive or congestive, will present with abnormalities in 
pulse rates, blood pressure and perfusion. There may be fluid overload 
or dehydration. Blood tests such as those used to determine a lactate 
level or ESR may assist in clarifying the situation, although a chest 
radiograph, electrocardiograph, echocardiograph and catherisation 
with measurements of CVP and cardiac pressure may be more helpful.
Metabolic diseases, including acute diarrhoea, would be best 
assessed clinically by history and features of the degree of 
dehydration. Urea and electrolytes and arterial blood gases evaluations 
are useful for confirming the clinical severity of the disease. Diabetes 
mellitus would be assessed through consideration of clinical 
history, acidotic breathing, urine dipsticks for glucose and ketones, 
serum glucose, arterial blood gas and urea and electrolytes. Renal 
dysfunction will be evaluated by consideration of urine and serum 
electrolytes, calcium, phosphate and magnesium evaluations, and 
appropriate urinary tract imaging. Overdose or drug toxicity such as 
salicyclate toxicity would be excluded by consideration of a drug history 
and by measurement of drug (salicyclate) levels.  
   
Severe infections, including severe sepsis, septicaemia and multi-
organ dysfunction, could also present with features of respiratory 
distress. Exclusion of such diagnosis is achieved through the 
consideration of clinical features, and supportive or confirmatory 
laboratory evidence of infection including coagulation screens, acute 
phase reactants and relevant culture evaluations.
Neurological conditions, including infections (meningitis, 
encephalitis) and conditions involving the brain stem, may present 
clinically with different patterns of respiration, e.g. neurogenic 
hyperventilation, Cheyne-Stokes breathing, and gasping respiration 
with associated signs of respiratory distress. Associated neurological 
features and laboratory investigations, including lumber punctures, 
serum and urine osmolalities and electrolytes for Diabetes Insipidus or 
syndrome of inappropriate secretion of antidiuretic hormone (SIADH), 
and imaging, e.g. computerised tomography, will help to differentiate 
these conditions.
Investigations of respiratory causes of respiratory distress
After the other common conditions of RDS are rapidly clinically 
excluded, it would be prudent to consider a respiratory cause for the 
RDS. Pneumonia is the commonest cause of acute deterioration 
and should be considered early on. In children with sticky eyes and 
staccato cough with respiratory distress a diagnosis of Chlamydia 
pneumonia should be considered while older children presenting 
with headaches and arthralgia and respiratory distress may have 
Mycoplasma pneumoniae infection.
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A chest radiograph is useful in determining the site and nature of the 
lesion. It helps to recognise foreign bodies, identify opacifications 
in lung parenchyma or bronchial tree, identify pleural effusions or 
pneumothoraces, recognise pulmonary tuberculosis, and identify 
cystic, nodular or reticular changes suggestive of lymphoid interstitial 
pneumonitis. A high resolution CT more clearly delineates the 
site and nature of the lesion but is often not required. Neither of 
these tests helps to confirm an aetiological diagnosis, although 
a lobar opacification is suggestive of Streptococcal pneumoniae 
infection, bulging of the interlobar fissures is suggestive of a 
Klebsiella pneumoniae infection, and a pneumatocele is suggestive 
of Staphylococcus aureus infection. Other tests that would more 
clearly detect infection include full blood counts with white blood cell 
differential, C-reactive protein or procalcitonin levels. Tests utilised 
to confirm an aetiological diagnosis include culturing of fluid from a 
usually sterile site, e.g. pleural effusion, blood cultures, nasopharyngeal 
aspirates evaluated for viral cultures, tuberculin skin tests and 
endotracheal, gastric aspirates and induced sputum.
Aetiology of respiratory infections      
As regards the aetiologies associated with pneumonia, Streptococcus 
pneumoniae is the commonest bacterial pathogen. There are 92 
different serotypes of Streptococcus pneumoniae, but just a few are 
currently associated with causing pneumonia in children. Most of the 
serotypes associated with pathology in children are covered in the 
currently licensed seven-valent conjugated pneumococcal vaccine. 
The incidence of the other previously common bacteria, Haemophilus 
influenzae, has decreased substantially since the introduction 
of the Hib vaccine. Other commonly implicated bacteria include 
Staphylococcus aureus and Klebseilla pneumoniae. Common viruses 
associated with respiratory tract infections include the respiratory 
syncytial virus, adenovirus, herpes, measles, parainfluenza and 
influenza. Also, the incidence of measles has been substantially 
reduced through the active implementation of the Expanded 
Programme of Immunisation. 
Atypical pathogens such as Chlamydia trachomatis and Mycoplasma 
pneumoniae are seen predominantly in early infancy or in children 
of school-going age. In HIV-infected infants, Pneumocystis jirovecii, 
cytomegalovirus and Mycobacterium tuberculosis are common 
opportunistic pathogens that are recognised in addition to the 
pathogens mentioned above. Pneumocystis jirovecii pneumonia 
accounts for one in four deaths in infancy amongst HIV-infected 
individuals, and the provision of co-trimoxazole (treatment and 
prophylaxis) and/or antiretroviral treatment could prevent these 
deaths.15,16 Tuberculosis occurs commonly in both HIV-infected and 
uninfected children.
Management of respiratory infections associated with respiratory 
distress
Effective interventions to reduce deaths associated with the 
clinical presentation of respiratory distress are available, but these 
interventions reach too few people. The WHO has utilised some of the 
clinical features of respiratory distress to classify children into different 
severities of pneumonia.17,18  
Children with just tachypnoea are classified as having pneumonia 
and treated with oral amoxicillin on an outpatient basis for five 
days. Children with chest indrawing, in addition to tachypnoea, 
are classified as having severe pneumonia and treatment includes 
parenteral penicillin for 48–72 hours followed by oral amoxicillin for 
five days as inpatients.19 If the child does not improve after 48 hours 
on benzylpenicillin, or if she/he worsens while on therapy, antibiotic 
therapy should be switched to parenteral chloramphenicol given every 
six hours. For patients with cyanosis and/or inability to drink (very 
severe pneumonia) the acute respiratory infections (ARI) guidelines 
recommend injectable benzylpenicillin plus gentamicin (2.5 mg/kg/dose 
every 8 hours) for 10 days. The guidelines for the management of 
severely malnourished children recommend ampicillin plus gentamicin 
for the treatment of severe pneumonia with complications,20 because 
there is a need to cover both Gram-positive and Gram-negative 
bacteria. Macrolides should be instituted where the presence of 
atypical pathogens is suspected.
In HIV-endemic areas parenteral co-trimoxazole should be 
administered to all infants, while oral co-trimoxazole as well as oral 
amoxicillin should be given to children with pneumonia treated as 
outpatients.21 Corticosteroids as well as oxygen should be given to 
hypoxaemic children with confirmed Pneumocystis jirovecii pneumonia. 
Ganciclovir should be considered for use in children with confirmed 
cytomegalovirus (CMV) in infection.22 As HIV-Infected children are 
predisposed to polymicrobial infections, early consideration should 
be given to cover for Mycobacterium tuberculosis or Staphylococcus 
aureus where evidence of its occurrence exists.23 It is estimated that 
around 600 000 lives could be saved each year at a cost of US$600 
million if antibiotics were universally delivered to children suffering from 
pneumonia. This figure could double if preventative measures such as 
expansion of vaccination could be universally implemented.24 
Supportive measures utilised in the management of children with 
respiratory distress include blood transfusion if haemoglobulin < 7 g/dl, 
antipyretic and analgesia – paracetamol 15mg/kg/dose 4–6 hourly if 
temperature > 38.5°C; nutritional support – 50 to 60 kcal/kg/day with 
adequate carbohydrates to prevent lactic acidosis; vitamin A if child 
has measles or malnutrition; and zinc at a dose of 20 mg/day for 7 to 
14 days.25 Intravenous fluids should only be administered if the child 
is shocked, having associated hyponatraemia or is too distressed to 
tolerate enterals. Mechanical ventilation should be considered if there 
is failure to maintain oxygen saturation above 90% on a polymask 
with an inspired oxygen concentration of > 70% or there is apnoea or 
hypercarbia with resultant acidosis or fatigue. Nebulisation with either 
beta agonists or anticholinergics should only be utilised in instances 
of reversible airway obstruction. There is no indication for the use of 
mucolytics, physiotherapy or postural drainage in these cases. In HIV-
infected children, the use of high active antiretroviral therapy should be 
considered once control of acute infection is attained.
Antibiotic resistance
Over the past few decades a large body of literature has reported 
on penicillin resistance in S pneumoniae from many developing 
countries.26,27 Drug resistance in S pneumoniae has been recognised 
in over 25% of cases. Fortunately the effect of antimicrobial resistance 
has not translated into worse outcomes in pneumococcal bacterial 
pneumonia when compared with susceptible pneumococcal 
isolates.28,29 Treatment with high dose amoxicillin (90 mg/kg/day) 
has been found to be effective in these cases. Macrolide-resistant 
Streptococci pneumoniae are also seen in up to a third of cases. 
Resistance to other antimicrobials used in the management of infection 
also occurs and local sensitivity patterns must be evaluated when 
making antibiotic policies.
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 Conclusions 
Severe/very severe pneumonia has a case fatality rate of 15–25% in 
developing countries with death usually occurring in the first three days 
of presentation, making early recognition by families and community 
health care workers a critical strategy in reducing mortality.30 Effective 
treatment requires an understanding of the common pathogens 
causing pneumonia and of administration of effective antibiotics by 
family practitioners. Appropriate assessment and management of 
respiratory distress in children has been shown to reduce the adverse 
impact of respiratory illnesses in childhood. A meta-analysis completed 
by Sazawal and Black has indicated that implementation of simple 
interventions as advocated by the WHO ARI algorithm has reduced all 
cause- and pneumonia-related mortality in children less than five years 
of age.28 The overall reduction in mortality rates among young infants, 
infants and children between one and five years of age was reduced 
by 42%, 36%, and 36% respectively while the pneumonia-related 
mortality was also decreased by 27%, 20% and 24% respectively.31 It 
is therefore imperative that health systems act urgently by undertaking 
training in the recognition of clinical features of respiratory distress 
and provide the tools for the implementation of planned interventions 
related to the recognition of the severely ill child. Such action would 
significantly reduce under-five mortality rates. South Africa, with its 
currently increasing childhood mortality rates, is unlikely to achieve the 
Millennium Development Goal 4 (of a two-thirds reduction in under-five 
mortality rates between 1990 and 2015) unless the government and 
private health systems urgently undertake to implement a programme 
that includes increased awareness of a recognised approach to a child 
suffering from respiratory distress.   
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